News

The trial showed a statistically significant and clinically meaningful improvement in progression-free survival (PFS) for patients treated with EPd compared with pomalidomide and dexamethasone (Pd) alone. ELOQUENT-3 is

However, the trial dubbed, Enforce, will be continued to study the drug’s performance in the treatment of episodic cluster headache as planned. Originally, the late-stage trial featured the

Top-line trial data were previously reported on 8 May 2018 and an update was provided on 11 May 2018. The biomarker data confirms that Traumakine treatment did not

Sage received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for SAGE-217 in MDD in February 2018, and recently announced an expedited development plan for

The trials, named GEMINI-1 and GEMINI-2, assessed the 2DR against a three-drug regimen of dolutegravir and two nucleoside reverse transcriptase inhibitors in HIV-1 patients with baseline viral loads

The acquisition of Sanofi’s manufacturing centre and business located in Holmes Chapel provides Recipharm with a solid platform to take further advantage of the growing respiratory drug market.

Roche chief medical officer and global product development head Sandra Horning said: “Today’s approval is an important advance for women newly diagnosed with this type of ovarian cancer.

The Boston-based clinical-stage biotechnology company had been conducting the mid-stage trials for the oral disintegrating tablet formulation in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT). Flex Pharma said

PFIC is a rare and life-threatening liver disease with no approved pharmacologic treatment option. A4250 is an ileal bile acid transporter (IBAT) inhibitor, which is being developed for